Could a daily vitamin fix B12 deficiency in diabetes patients?
NCT ID NCT06983223
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a special oral vitamin B12 supplement (Sucrosomial® B12) can raise B12 levels in people with type 2 diabetes who have low B12 due to taking metformin. Fifty adults took either the supplement or a placebo daily for 3 weeks. The goal was to see if the supplement could correct the deficiency and improve related blood markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sucrosomial® Vitamin B12 (an oral vitamin B12 supplement)
- What this could lead to
- If it works, this could offer a simple, daily supplement to manage B12 deficiency in people with type 2 diabetes who take metformin.
- What could go wrong
- This is a small, short-term study (50 people, 4 weeks). Results may not apply to everyone, and the supplement may not work better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Liaquat University of Medical & Health Sciences (LUMHS)
Jāmshoro, Sindh, 76090, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your gut bacteria hold the key to protecting your kidneys?
- Muscle-Saving supplement may shield seniors from Weight-Loss drug side effect
- Can diabetes disrupt the Brain-Heart link?
- A scent of citrus: could bitter orange oil ease fatigue and aid sleep in diabetes?
- Gut bacteria swap may tame diabetes and thyroid disease
- A blood marker may reveal how well diabetes treatments are working